Quest Diagnostics Incorporated Stock Analysis

Quest Stock Analysis Notes

About 100.0% of the company shares are held by institutions such as insurance companies. The book value of Quest Diagnostics was currently reported as 65.18. The company has Price/Earnings To Growth (PEG) ratio of 1.46. Quest Diagnostics recorded earning per share (EPS) of 8.66. The entity last dividend was issued on the 6th of April 2026. The firm had 2:1 split on the 21st of June 2005. Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. Quest Diagnostics operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 50000 people. To learn more about Quest Diagnostics Incorporated call Stephen Rusckowski at 973 520 2700 or check out https://www.questdiagnostics.com.

Quest Diagnostics Investment Alerts

Quest Largest EPS Surprises

View All Earnings Estimates

Quest Diagnostics Environmental, Social, and Governance (ESG) Scores

Quest Stock Institutional Investors

Note, although Quest Diagnostics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Quest Market Capitalization

The company currently falls under 'Large-Cap' category with a total capitalization of 22.52 B.

Quest Profitablity

The company has Net Profit Margin of 0.09 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.14 %, which entails that for every 100 dollars of revenue, it generated $0.14 of operating income.

Management Efficiency

Quest Diagnostics has Return on Asset of 0.0641 % which means that on every $100 spent on assets, it made $0.0641 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1475 %, implying that it generated $0.1475 on every 100 dollars invested. Quest Diagnostics' management efficiency ratios could be used to measure how well Quest Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.14 in 2026. Return On Capital Employed is likely to drop to 0.10 in 2026. At this time, Quest Diagnostics' Fixed Asset Turnover is fairly stable compared to the past year. Asset Turnover is likely to rise to 0.97 in 2026, whereas Total Assets are likely to drop slightly above 9.1 B in 2026.

Technical Drivers

As of the 20th of February, Quest Diagnostics holds the Risk Adjusted Performance of 0.0694, semi deviation of 0.9978, and Coefficient Of Variation of 1194.46. Quest Diagnostics technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices.

Quest Diagnostics Price Movement Analysis

Quest Diagnostics Insider Trading Activities

Quest Diagnostics Outstanding Bonds

Quest Diagnostics Predictive Daily Indicators

Quest Diagnostics Corporate Filings

Quest Diagnostics Forecast Models

Quest Diagnostics' time-series forecasting models are one of many Quest Diagnostics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Quest Diagnostics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Quest Diagnostics Bond Ratings

Quest Diagnostics Incorporated financial ratings play a critical role in determining how much Quest Diagnostics have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Quest Diagnostics' borrowing costs.

Quest Diagnostics Debt to Cash Allocation

Quest Diagnostics Incorporated has 6.92 B in debt with debt to equity (D/E) ratio of 0.73, which is OK given its current industry classification. Quest Diagnostics has a current ratio of 1.43, which is typical for the industry and considered as normal. That said, strategic use of leverage may enable Quest to fund expansion initiatives and generate superior returns.

Quest Diagnostics Total Assets Over Time

Quest Diagnostics Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Quest Diagnostics uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Quest Diagnostics Debt Ratio

29.0

It appears most of the Quest Diagnostics' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Quest Diagnostics' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Quest Diagnostics, which in turn will lower the firm's financial flexibility.

Quest Diagnostics Corporate Bonds Issued

Quest Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Quest Diagnostics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Quest shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Quest Diagnostics. By using and applying Quest Stock analysis, traders can create a robust methodology for identifying Quest entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Quest analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Quest analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Quest Diagnostics Incorporated stock analysis indicators help investors evaluate how Quest Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Quest Diagnostics shares will generate the highest return on investment. By understating and applying Quest Diagnostics stock analysis, traders can identify Quest Diagnostics position entry and exit signals to maximize returns.

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.